Global Partners GLP 深 沪
已收盘 08-14 16:00:00 美东时间
50.83
+1.000
+2.01%
华盛通- 最 高51.14
- 今 开50.00
- 成交量 12.16万股
- 最 低 50.00
- 昨 收 49.83
- 总市值 17.28亿
- 52周最高 51.58
- 市盈率 静 24.12
- 换手率 0.36%
- 52周最低 36.64
- 委 比 -99.00%
- 总股本 3399.56万
- 历史最高 55.445
- 量 比 0.85
- 振 幅 2.29%
- 历史最低 -15.375
- 每 手 1
- 风险率 3.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LiveOne (LVO) 2027财年第一季度业绩电话会议：营收1940万美元，PodcastOne实现增长
LiveOne 的 2027 财年第一季度业绩电话会议涵盖了 1940 万美元的营收、创纪录的 PodcastOne 销售额、一次性 EBITDA 收益以及 B2B 业务拓展。
08-14 08:29
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
Alamar Biosciences expands its partnership with Alzheimer's Disease Data Initiative and Gates Ventures, adding 86,000 plasma samples using NULISAseq™ Neuro 220 to study neurodegenerative disease heterogeneity. The combined dataset, expected to include over 140,000 samples by 2027, aims to provide deeper insights into disease subtypes and trajectories through multiplex protein profiling.
08-10 20:03
Global Partners declares $0.78 dividend
Global Partners (GLP) declares $0.78/share quarterly dividend, in line with previous. Forward yield 6.22% Payable Aug. 14; for shareholders of record Aug. 10; ex-div Aug. 10. See GLP Dividend Scorecar...
08-10 16:09
Global Partners Q2 EPS $1.86 Beats $1.24 Estimate, Sales $6.792B Miss $7.507B Estimate
Global Partners (NYSE:GLP) reported quarterly earnings of $1.86 per share which beat the analyst consensus estimate of $1.24 by 50 percent. This is a 238.18 percent increase over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $6.792 billion which ...
08-07 20:00
Wearable Devices Announces Pricing of $3.3 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
Wearable Devices Ltd. has entered into a securities purchase agreement with an institutional investor to sell 1,000,000 ordinary shares and warrants for $3.285 per share. The offering is expected to raise $3.3 million, with proceeds allocated to Mudra product commercialization, next-gen product development, AI6 Labs initiatives, and general corporate purposes. The closing is set for August 3, 2026, subject to customary conditions.
07-31 12:00
DarioHealth prices $23.5M registered direct offering
DarioHealth (NASDAQ: DRIO) said on Wednesday it priced a $23.5M registered direct offering of 3.45M common shares at $6.80 per share, in compliance with Nasdaq rules. The offering includes the purcha...
07-22 20:12
Aptera Motors Announces a Warrant Inducement Transaction for $5.7 Million in Gross Proceeds
Aptera Motors Corp. announced the immediate exercise of warrants to purchase up to 2.775 million shares of Class B Common Stock at $2.07 per share, generating approximately $5.7 million in gross cash proceeds. In exchange, the company will issue new warrants for up to 4.1625 million shares with an exercise price of $2.25 per share, exercisable six months after issuance and expiring in five and a half years. A.G.P./Alliance Global Partners is acti...
07-10 12:00
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Nurix Therapeutics announced a global collaboration with Roche for its BTK degrader bexobrutideg, with potential total payments of up to $2.3 billion, including a $700 million upfront payment. The partnership includes co-development and co-commercialization across malignant hematology, immunology, and neurology, with planned Phase 2 studies in multiple sclerosis and chronic spontaneous urticaria. Nurix also presented clinical data supporting bexo...
07-09 20:01
Associate Global Partners Updates Director Martin Switzer’s Investment Holdings
Contango Asset Management Ltd. ( ($AU:APL) ) just unveiled an announcement. Ass...
07-08 09:37
Associate Global Partners Expands Quoted Share Base on ASX
Contango Asset Management Ltd. ( ($AU:APL) ) has issued an announcement. Associ...
07-06 09:57
